# Serum-Free Cell Culture Media Market Size, Growth & Forecast 2026–2035

> The Global Serum-Free Cell Culture Media market was valued at USD 1,268.9 Mn in 2025 and is projected to reach USD 3,516.3 Mn by 2035, growing at a 10.73% CAGR during 2026–2035, according to Vectomat Insights. North America leads with a 36.0% share, ready-to-use media hold 52.0% of revenue, and Asia Pacific is the fastest-growing region as South Korea scales biologics capacity.

- Publisher: Vectomat Insights
- Report code: VMI-1-4-24679
- Published: 2026-11-15
- Canonical URL: https://www.vectomatinsights.com/report/serum-free-cell-culture-media-market
- Base year 2025: USD 1,268.9 Mn
- Forecast 2035: USD 3,516.3 Mn
- CAGR 2026–2035: 10.73%

## Key insights

- The market grows from USD 1,268.9 Mn in 2025 to USD 3,516.3 Mn by 2035 at a 10.73% CAGR, according to Vectomat Insights.
- Ready-to-Use Media is the dominant product category at 52.0% of 2025 revenue (USD 659.8 Mn) and also the fastest-growing, at a 13.4% CAGR to 2035.
- Biopharmaceutical Production is the dominant application at 56.0% (USD 710.7 Mn), because large CHO fed-batch runs consume media by the thousand litres.
- Cell & Gene Therapy Manufacturing is the fastest-growing application, forecast at a 15.41% CAGR, up from USD 118.6 Mn in 2023 to USD 177.6 Mn in 2025.
- Biopharmaceutical Manufacturers are the dominant end user at 57.5% of revenue, buying under multi-year agreements tied to validated processes.
- North America leads regionally with a 36.0% share (USD 456.8 Mn); the United States alone accounts for USD 356.3 Mn.
- Asia Pacific is the fastest-growing region, with South Korea forecast at a 12.9% CAGR, the highest of any tracked country.
- Consolidation is reshaping the supplier tier: Merck KGaA agreed in June 2026 to acquire Bio-Techne for USD 11.3 Bn.
- The FDA's April 2025 plan to reduce animal testing for monoclonal antibodies widens demand for defined media used in human cell-based test systems.

## Figures

![Serum-Free Cell Culture Media market size — USD 1,268.9 Mn (2025) to USD 3,516.3 Mn (2035), 10.73% CAGR | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-size-vmi.png) — The Global Serum-Free Cell Culture Media market grows from USD 1,268.9 Mn in 2025 to USD 3,516.3 Mn by 2035, a 10.73% CAGR. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![Serum-Free Cell Culture Media market DROC analysis — capacity, cell therapy and regulation drive growth | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-droc-vmi.png) — Biologics capacity, cell and gene therapy and the shift away from animal inputs drive the market, while cost per litre and switching costs restrain it. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![Serum-Free Cell Culture Media market share by region — North America leads with 36.0% in 2025 | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-regional-share-vmi.png) — North America leads the Global Serum-Free Cell Culture Media market with a 36.0% share in 2025, while Asia Pacific grows fastest. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![Serum-Free Cell Culture Media market segmentation — ready-to-use media lead at 52.0% | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-segments-vmi.png) — Ready-to-Use Media, Biopharmaceutical Production, CHO Cell Media and Biopharmaceutical Manufacturers lead their segmentation dimensions in 2025. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![Serum-Free Cell Culture Media market share by product — Ready-to-Use Media 52.0% in 2025 | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-product-share-vmi.png) — Ready-to-Use Media holds 52.0% of the Global Serum-Free Cell Culture Media market by product in 2025. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![Serum-Free Cell Culture Media market share by end user — Biopharmaceutical Manufacturers 57.5% in 2025 | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-end-user-share-vmi.png) — Biopharmaceutical Manufacturers holds 57.5% of the Global Serum-Free Cell Culture Media market by end user in 2025. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![Serum-Free Cell Culture Media product mix by region — ready-to-use media lead in all top 3 regions | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-regional-segments-vmi.png) — Ready-to-use media lead the product mix in North America, Europe and Asia Pacific, with the highest share in North America at 54.5%. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![Serum-Free Cell Culture Media competitive landscape — Thermo Fisher, Merck KGaA, Sartorius, Cytiva lead | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-competitive-landscape-vmi.png) — Thermo Fisher Scientific, Merck KGaA, Sartorius and Cytiva combine bioprocess scale with broad media portfolios, while specialists compete on advanced-therapy depth. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![Serum-Free Cell Culture Media market at a glance — USD 1,268.9 Mn (2025) to USD 3,516.3 Mn, 10.73% CAGR | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-key-numbers-vmi.png) — Key numbers for the Global Serum-Free Cell Culture Media market: size, growth, leading segments, regions and companies. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![United States Serum-Free Cell Culture Media market — USD 356.3 Mn (2025) to USD 883.0 Mn (2035) | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-united-states-snapshot-vmi.png) — The United States Serum-Free Cell Culture Media market grows from USD 356.3 Mn in 2025 to USD 883.0 Mn by 2035 at a 9.5% CAGR. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![Germany Serum-Free Cell Culture Media market — USD 103.0 Mn (2025) to USD 246.1 Mn (2035) | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-germany-snapshot-vmi.png) — The Germany Serum-Free Cell Culture Media market grows from USD 103.0 Mn in 2025 to USD 246.1 Mn by 2035 at a 9.1% CAGR. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.
![South Korea Serum-Free Cell Culture Media market — USD 62.7 Mn (2025) to USD 211.0 Mn (2035) | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/serum-free-cell-culture-media-market/8732c0816763c51c/serum-free-cell-culture-media-market-south-korea-snapshot-vmi.png) — The South Korea Serum-Free Cell Culture Media market grows from USD 62.7 Mn in 2025 to USD 211.0 Mn by 2035 at a 12.9% CAGR. Source: Vectomat Insights, Serum-Free Cell Culture Media Market Report.

## Market size (USD million)

| Year | Value |
|---|---|
| 2023 | 1,085.0 |
| 2024 | 1,181.7 |
| 2025 | 1,268.9 |

## Share by Product (2025)

| Segment | Share | USD Mn |
|---|---|---|
| Ready-to-Use Media | 52% | 659.8 |
| Custom-Formulated Media | 30% | 380.7 |
| Supplements & Additives | 18% | 228.4 |

## Share by Application (2025)

| Segment | Share | USD Mn |
|---|---|---|
| Biopharmaceutical Production | 56% | 710.7 |
| Vaccine Development | 24% | 304.5 |
| Cell & Gene Therapy Manufacturing | 14% | 177.6 |
| Diagnostics and assay development | 6% | 76.1 |

## Share by Cell Type (2025)

| Segment | Share | USD Mn |
|---|---|---|
| CHO Cell Media | 45.5% | 577.3 |
| Stem Cell Media | 22% | 279.2 |
| HEK293 Media | 18.3% | 231.6 |
| CHO-adjacent and BHK-21 media | 14.2% | 180.8 |

## Share by End User (2025)

| Segment | Share | USD Mn |
|---|---|---|
| Biopharmaceutical Manufacturers | 57.5% | 729.6 |
| CDMOs | 28% | 355.3 |
| Academic & Research Institutes | 14.5% | 184.0 |

## Regional share

| Region | Share | USD Mn |
|---|---|---|
| North America | 36% | 456.8 |
| Europe | 28.37% | 360.1 |
| Asia Pacific | 26% | 329.9 |
| Latin America | 4% | 50.8 |
| The Middle East | 3.06% | 38.8 |
| Africa | 2.57% | 32.6 |

## Key companies

- Thermo Fisher Scientific (U.S.): Gibco chemically defined bioproduction and cell therapy media
- Merck KGaA (Germany): CHO media platforms and custom media development (MilliporeSigma)
- Sartorius (Germany): Media for cell therapy, gene therapy and vaccines (incl. former Xell AG)
- Cytiva (U.S.): Liquid and powder media, feeds and buffers at bioprocess scale
- Lonza (Switzerland): TheraPEAK xeno-free and chemically defined media for cell and gene therapy
- Corning (U.S.): Serum-free MSC and custom media paired with cell culture vessels
- FUJIFILM Biosciences (U.S.): BalanCD chemically defined bioprocess and HEK293 media
- Bio-Techne (U.S.): GMP proteins, cytokines and media supplements for cell therapy
- Takara Bio (Japan): Xeno-free stem cell, MSC and T-cell media
- Ajinomoto (Japan): Amino-acid-based CHO media, feeds and AAV supplements (incl. Ajinomoto CELLiST Korea)
- Evonik (Germany): Cell culture ingredients: peptides, lipids and animal-free albumin
- PromoCell (Germany): Primary cell media and custom GMP media
- Capricorn Scientific (Germany): Animal-free media, including Vero expression media for vaccines
- Nucleus Biologics (U.S.): Custom media and buffers for cell therapy
- Trailhead Biosystems (U.S.): Defined iPSC differentiation media and human cell products

## FAQs

### What does the VMI Serum-Free Cell Culture Media report include?

The report includes market sizing and CAGR forecasts for 2026–2035, segmentation across Product, Application, Cell Type and End User, a Production & Volume analysis in litres, regional and country analysis for 35+ geographies, profiles of 15 companies, and a full research methodology, delivered as a 300+ page PDF with 96 tables and 72 figures, according to Vectomat Insights.

### What is the Serum-Free Cell Culture Media market size and forecast?

The Global Serum-Free Cell Culture Media market stood at USD 1,268.9 Mn in 2025 and is projected to reach USD 3,516.3 Mn by 2035, a 10.73% CAGR over 2026–2035. Ready-to-Use Media, the largest product category at 52.0%, also grows fastest at 13.4% a year. North America holds 36.0% of demand, and Asia Pacific is the fastest-growing region, led by South Korea at a 12.9% CAGR, according to Vectomat Insights.

### How is the Serum-Free Cell Culture Media market segmented in this report?

This report segments the market by Product (Ready-to-Use Media dominant and fastest-growing), by Application (Biopharmaceutical Production dominant, Cell & Gene Therapy Manufacturing fastest-growing at 15.41%), by Cell Type (CHO Cell Media dominant, CHO-adjacent and BHK-21 media fastest-growing), and by End User (Biopharmaceutical Manufacturers dominant, Academic & Research Institutes fastest-growing), according to Vectomat Insights.

### Which countries are covered in this report?

This report covers all six VMI regions: North America (The U.S., Canada, Mexico), Europe (Germany, France, U.K. and more), Asia Pacific (China, Japan, India, South Korea and more), Latin America, The Middle East and, as its own region, Africa; the two are never combined. Country snapshots cover the United States, Germany and South Korea, according to Vectomat Insights.

### What customization options are available?

Vectomat Insights offers customization across additional segments such as specific cell lines or media formats, extra countries, extended forecast periods and additional company profiles. Buyers can also request supplier benchmarking or price-per-litre analysis for their own process. Deliverables can include Excel data packs. Contact sales@vectomatinsights.com to scope a custom Serum-Free Cell Culture Media report, according to Vectomat Insights.

### How can I access or purchase the Serum-Free Cell Culture Media report?

The report is available as a free sample, a full purchase or a custom inquiry through the Vectomat Insights website, delivered electronically as a PDF with an Excel add-on available on request. The sample previews the data tables, segmentation depth and regional forecasts. For pricing, licensing for multiple users or custom scope, contact sales@vectomatinsights.com, according to Vectomat Insights.

### What research methodology does VMI use for this report?

VMI combines interviews with upstream process scientists, CDMO operations leads, cell therapy engineers and media suppliers with company filings, regulatory databases and bioprocess literature. Segment and regional values are reconciled to the base-year total and cross-checked against reported supplier revenue, using top-down and bottom-up triangulation, and growth rates are tested against capacity and pipeline trends, according to Vectomat Insights.

Cite as: Vectomat Insights (2026). Serum-Free Cell Culture Media Market Report. https://www.vectomatinsights.com/report/serum-free-cell-culture-media-market